Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Coronavirus Report – Part 91: GSK Japan President Paul Lirette Discusses Strategy and Moves in Pandemic Times

Filed Under: Coronavirus, Interviews, Pharma Tagged With: , , , , , , , ,

A global leader in its field, GlaxoSmithKline PLC (GSK) has been developing vaccines against a myriad of infectious diseases for…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Just How Effective Will Vaccines Be in Combating the COVID-19 Pandemic?
Just How Effective Will Vaccines Be in Combating the…
Column: COVID-19 Brings Major Changes to Vaccine Development
Column: COVID-19 Brings Major Changes to Vaccine Development
Coronavirus Report – Part 89: Japanese Materials and Chemicals Companies See Rush of Contract Production Activity
Coronavirus Report – Part 89: Japanese Materials and…
Spate of Japanese-Developed COVID-19 Vaccines Head Into Later Stages of Development, Clinical Trials
Spate of Japanese-Developed COVID-19 Vaccines Head Into…
METI Plans Major Funding for Biopharma Sector to Bolster Economic Security
METI Plans Major Funding for Biopharma Sector to Bolster…
Dry Ice to Play Central Role in Successful Management of Coronavirus Vaccines
Dry Ice to Play Central Role in Successful Management of…